Quote from Informed:
Suggest short May at money straddles to take advantage of the high premiums. I predict FDA will approve, but the share price won't move above 50.
Target price
Approval 50 (50%)
Approval with tough restriction or post approval study 45 (25%)
Request more data but no more new trial 38 or other delay (20%)
More data new trial 22 (5%)
You forgot one outcome on your %'s above LOL
Hope you didnt follow your own advice.
If I were you I would lay off the predictions for a while till your crystal ball clears up.
